Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON™
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, […]
Orbit Discovery and WuXi AppTec Sign Agreement to Access Peptide Discovery and Optimisation Technologies
Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a […]
Maverick Medical AI Closes a $5M Seed Investment Round for Accelerating Development of its mCoder™ Artificial Intelligence Platform for Additional Clinical Domains
Maverick Medical AI (“Maverick”, the “Company”) has announced that it has closed a $5 million seed investment from […]
Immunovia Further Strengthens IP Portfolio for its IMMray ™ PanCan-d Signature
Immunovia AB (publ) announced today that the United States Patent and Trademark Office (USPTO) has […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Kit Check Hires New Chief Financial Officer
Kit Check, the leader in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient […]
Bayer Announces Changes in Executive Leadership Team of Crop Science Division
Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
Genome and Company Announces Clinical Trial Collaboration with MSD to Evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in Phase 2 Clinical Trial in Biliary Tract Cancer Patients
Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug […]
Lynx Introduces Modern FinTech to Healthcare—Launches with $17.5M in Funding
Lynx, the leading API-connected healthcare payments, banking, and e-commerce platform, announced today that it has emerged […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more